1. Home
  2. MYPS vs SER Comparison

MYPS vs SER Comparison

Compare MYPS & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PLAYSTUDIOS Inc.

MYPS

PLAYSTUDIOS Inc.

N/A

Current Price

$4.22

Market Cap

60.3M

Sector

Technology

ML Signal

N/A

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

N/A

Current Price

$1.48

Market Cap

56.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYPS
SER
Founded
2011
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.3M
56.4M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
MYPS
SER
Price
$4.22
$1.48
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $9.50
AVG Volume (30 Days)
★ 71.0K
67.3K
Earning Date
11-05-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $235,097,000.00
$130,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 132.14
52 Week Low
$0.40
$1.14
52 Week High
$5.24
$4.26

Technical Indicators

Market Signals
Indicator
MYPS
SER
Relative Strength Index (RSI) 56.66 43.26
Support Level $4.21 $1.59
Resistance Level $5.10 $2.13
Average True Range (ATR) 0.38 0.32
MACD -0.11 -0.01
Stochastic Oscillator 52.45 33.33

Price Performance

Historical Comparison
MYPS
SER

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Companies games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: